Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04520061 · ClinicalTrials.gov registry record · NA
Developing a Health Insurance Navigation Program for Survivors of Childhood Cancer
A NA study of Childhood Cancer Survivors and Health Insurance, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
- 1
- Study location
NCT04520061: Completed NA study of Childhood Cancer Survivors and Health Insurance, sponsored by Massachusetts General Hospital.
NCT04520061 is a NA study of Childhood Cancer Survivors and Health Insurance that has completed, run by Massachusetts General Hospital. The registered enrollment target is 82 participants, below the 982-participant average among 6 other Childhood Cancer Survivors trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04520061, a NA study of Childhood Cancer Survivors and Health Insurance, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
- 1
- Study location
Study Summary
Dr. Park and her colleagues published findings in the Journal of Clinical Oncology demonstrating that CCSS survivors, compared to siblings, were significantly more likely to be uninsured and to have difficulties obtaining health insurance. Given the current insurance landscape and the additional insurance burden that childhood cancer survivors face, the present study seeks to develop and pilot a health insurance navigation program targeted at feasibility and acceptability with survivors, and improving health insurance literacy and ameliorating financial distress related to medical costs. The proposed health insurance navigation will involve 4 navigator-led health insurance navigation sessions. The study investigators propose that, compared to the control arm (who will receive a health insurance information guide, but will not receive the navigation intervention), participants in the intervention arm will have improved health insurance literacy and decreased financial distress related to medical costs.
Primary Outcome
10-point (1-10; 1= least helpful and 10= most helpful) scale rating of program quality, including the following (higher scores indicate higher levels of acceptability)- * program materials * scheduling * communication with navigator * length and number of sessions (investigator created scale)
Conditions Studied
Interventions
- BEHAVIORAL Health Insurance Navigation Program
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2020-08-25 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT04520061 record still lists
NCT04520061 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 982-participant average among 6 other Childhood Cancer Survivors trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Childhood Cancer Survivors appearing as the primary indexed condition, and to 1 intervention - of which Health Insurance Navigation Program is the first listed.
NCT04520061 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT04520061 about?
NCT04520061 is a clinical study titled "Developing a Health Insurance Navigation Program for Survivors of Childhood Cancer". Dr. Park and her colleagues published findings in the Journal of Clinical Oncology demonstrating that CCSS survivors, compared to siblings, were significantly more likely to be uninsured and to have difficulties obtaining health insurance. Given the current insurance landscape and the additional ins...
What is the current status of trial NCT04520061?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2020-08-25. Estimated completion is 2022-12-31.
What conditions does trial NCT04520061 study?
This clinical trial studies the following conditions: Childhood Cancer Survivors, Health Insurance.
What interventions are being tested in trial NCT04520061?
The interventions under investigation include: Health Insurance Navigation Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04520061?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04520061 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Cancer Survivors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
RECRUITING · NA
-
A Study of Time-Restricted Eating in Childhood Cancer Survivors
RECRUITING · NA
-
Overnight Fasting After Completion of Therapy: The OnFACT Study
ACTIVE NOT RECRUITING · NA
-
Virtual Health Insurance Navigation Pilot Program for Childhood Survivors (HINTII)
ACTIVE NOT RECRUITING · NA
-
Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial
ACTIVE NOT RECRUITING · NA
-
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI